125 related articles for article (PubMed ID: 3997307)
1. Bioavailability and central side effects of different carbamazepine tablets.
Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):226-32. PubMed ID: 3997307
[TBL] [Abstract][Full Text] [Related]
2. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of two carbamazepine tablets.
Glende M; Hüller H; Mai I; Migulla H; Prümke J; Schumann G
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):631-3. PubMed ID: 6668101
[TBL] [Abstract][Full Text] [Related]
4. The bioavailability of carbamazepine.
Cotter LM; Smith G; Hooper WD; Tyrer JH; Eadie MJ
Proc Aust Assoc Neurol; 1975; 12():123-8. PubMed ID: 1215378
[TBL] [Abstract][Full Text] [Related]
5. [Carbamazepine: the bioavailability of 4 oral pharmaceutical products].
Saavedra I; Passalacqua A; Chávez H; Biagini L; Galdames D
Rev Med Chil; 1990 Oct; 118(10):1123-8. PubMed ID: 2152631
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
[TBL] [Abstract][Full Text] [Related]
7. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
8. A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation.
Maas B; Garnett WR; Pellock JM; Comstock TJ
Ther Drug Monit; 1987; 9(1):28-33. PubMed ID: 3576660
[TBL] [Abstract][Full Text] [Related]
9. Comparison of absorption rate and bioavailability of two brands of carbamazepine.
Revankar SN; Desai ND; Bhatt AD; Bolar HV; Sane SP; Gupta C; Kamat DV
J Assoc Physicians India; 1999 Jul; 47(7):699-702. PubMed ID: 10778590
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
11. Effect of the timing of food intake on the absorption and bioavailability of carbamazepine immediate-release tablets in beagle dogs.
Xu CH; Cheng G; Liu Y; Tian Y; Yan J; Zou MJ
Biopharm Drug Dispos; 2012 Jan; 33(1):30-8. PubMed ID: 22271001
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
[TBL] [Abstract][Full Text] [Related]
13. Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1997 Jun; 47(6):755-7. PubMed ID: 9239455
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.
Ogata H; Aoyagi N; Kaniwa N; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):240-5. PubMed ID: 6746147
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
Khalafalla N; Elgholmy ZA; Khalil SA
Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
18. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
20. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
Babalola CP; Oladimeji FA; Femi-Oyewo MN
Afr J Med Med Sci; 2001 Dec; 30(4):275-80. PubMed ID: 14510103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
